ArticleScientific reports2019

The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors.

Francesca Coperchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.